Biotechnology: Biological Products (No Diagnostic Substances)

Notable Posts

Loading...

Analysis

On Tuesday, June 22, we saw neutral social sentiment for stocks in the biotechnology: biological products (no diagnostic substances) industry. We gave it a score of 8. There was a significant amount of activity, such as likes and shares, on social media.

Over the prior 7 days we calculated an average sentiment score of 10 (neutral). Over the prior 14 days our AI scored an average sentiment of 10 (neutral). And for the prior 30 days our social sentiment score for stocks in the biotechnology: biological products (no diagnostic substances) industry is 9 (neutral).

Stocks In This Industry

10x Genomics Inc (TXG)
9 Meters Biopharma Inc. (NMTR)
Acceleron Pharma Inc. (XLRN)
Acorda Therapeutics, Inc. (ACOR)
Adaptimmune Therapeutics plc (ADAP)
ADiTx Therapeutics Inc. (ADTX)
ADMA Biologics Inc (ADMA)
Adverum Biotechnologies, Inc. (ADVM)
Aerie Pharmaceuticals, Inc. (AERI)
Aevi Genomic Medicine, Inc. (GNMX)
Agenus Inc. (AGEN)
AIkido Pharma Incorporated (AIKI)
Akouos Inc. (AKUS)
Alector Inc. (ALEC)
Allena Pharmaceuticals, Inc. (ALNA)
Allogene Therapeutics, Inc. (ALLO)
AlloVir Inc (ALVR)
Amgen Inc. (AMGN)
AmpliPhi Biosciences Corporation (APHB)
Applied Genetic Technologies Corporation (AGTC)
Applied Molecular Transport Inc. (AMTI)
Applied Therapeutics Inc. (APLT)
Aptose Biosciences, Inc. (APTO)
argenx SE (ARGX)
Arsanis, Inc. (ASNS)
Aspira Women's Health Inc. (AWH)
Asterias Biotherapeutics, Inc. (AST)
Atara Biotherapeutics, Inc. (ATRA)
aTyr Pharma, Inc. (LIFE)
Audentes Therapeutics, Inc. (BOLD)
Autolus Therapeutics plc (AUTL)
Avidity Biosciences Inc (RNA)
AVROBIO, Inc. (AVRO)
Axcella Health Inc. (AXLA)
Axovant Gene Therapies Ltd. (AXGT)
Beam Therapeutics Inc. (BEAM)
BELLUS Health Inc. (BLU)
BioCardia Inc. (BCDA)
BioCryst Pharmaceuticals, Inc. (BCRX)
Biogen Inc. (BIIB)
BiondVax Pharmaceuticals Ltd. (BVXV)
BioNTech SE (BNTX)
Bio-Techne Corp (TECH)
BioTime, Inc. (BTX)
Black Diamond Therapeutics Inc. (BDTX)
bluebird bio, Inc. (BLUE)
Brainstorm Cell Therapeutics Inc. (BCLI)
Cabaletta Bio Inc. (CABA)
CASI Pharmaceuticals, Inc. (CASI)
Cellectis S.A. (CLLS)
Cellular Biomedicine Group, Inc. (CBMG)
Cel-Sci Corporation (CVM)
Champions Oncology, Inc. (CSBR)
Checkmate Pharmaceuticals Inc. (CMPI)
China Biologic Products Holdings, Inc. (CBPO)
Cidara Therapeutics, Inc. (CDTX)
Coherus BioSciences, Inc. (CHRS)
Compugen Ltd. (CGEN)
Conversion Labs Inc (CVLB)
Cortexyme Inc. (CRTX)
CRISPR Therapeutics AG (CRSP)
Curis, Inc. (CRIS)
CytRx Corporation (CYTR)
DBV Technologies S.A. (DBVT)
Denali Therapeutics Inc. (DNLI)
Dyadic International Inc. (DYAI)
Editas Medicine, Inc. (EDIT)
Eiger BioPharmaceuticals, Inc. (EIGR)
Enlivex Therapeutics Ltd. (ENLV)
Entera Bio Ltd. (ENTX)
Erytech Pharma S.A. (ERYP)
Fate Therapeutics, Inc. (FATE)
Fennec Pharmaceuticals Inc. (FENC)
Forte Biosciences Inc. (FBRX)
Frequency Therapeutics Inc. (FREQ)
Gamida Cell Ltd. (GMDA)
Genetic Technologies Ltd (GENE)
Genocea Biosciences, Inc. (GNCA)
Gilead Sciences, Inc. (GILD)
Gritstone Oncology, Inc. (GRTS)
Halozyme Therapeutics, Inc. (HALO)
Harpoon Therapeutics Inc. (HARP)
Hemispherx BioPharma, Inc. (HEB)
Heska Corporation (HSKA)
Histogen Inc. (HSTO)
Humanigen Inc (HGEN)
Idera Pharmaceuticals, Inc. (IDRA)
Immatics N.V. (IMTX)
Inhibrx Inc (INBX)
Inmune Bio Inc. (INMB)
Iovance Biotherapeutics, Inc. (IOVA)
iTeos Therapeutics Inc. (ITOS)
IVERIC bio Inc. (ISEE)
Jounce Therapeutics, Inc. (JNCE)
Kodiak Sciences Inc (KOD)
Krystal Biotech, Inc. (KRYS)
Kymera Therapeutics Inc. (KYMR)
La Jolla Pharmaceutical Company (LJPC)
Larimar Therapeutics Inc. (LRMR)
Liminal BioSciences Inc. (LMNL)
Liquidia Technologies, Inc. (LQDA)
Lixte Biotechnology Holdings Inc (LIXT)
LogicBio Therapeutics, Inc. (LOGC)
Lumos Pharma Inc. (LUMO)
Medicenna Therapeutics Corp. (MDNA)
MeiraGTx Holdings plc (MGTX)
Mesoblast Limited (MESO)
Microbot Medical Inc. (MBOT)
Mimedx Group Inc (MDXG)
Moderna, Inc. (MRNA)
Momenta Pharmaceuticals, Inc. (MNTA)
Monopar Therapeutics Inc (MNPR)
Morphic Holding Inc. (MORF)
NanoString Technologies, Inc. (NSTG)
NantKwest, Inc. (NK)
Neon Therapeutics, Inc. (NTGN)
Neuralstem, Inc. (CUR)
NeuroBo Pharmaceuticals Inc. (NRBO)
Neurocrine Biosciences, Inc. (NBIX)
NextCure Inc. (NXTC)
NGM Biopharmaceuticals Inc. (NGM)
Nightstar Therapeutics plc (NITE)
Nkarta Inc. (NKTX)
Novavax, Inc. (NVAX)
Ocugen Inc (OCGN)
Orchard Therapeutics plc (ORTX)
Organovo Holdings, Inc. (ONVO)
Osiris Therapeutics, Inc. (OSIR)
Outlook Therapeutics, Inc. (OTLK)
Pandion Therapeutics Inc. (PAND)
Passage Bio Inc. (PASG)
PDL BioPharma, Inc. (PDLI)
Personalis Inc. (PSNL)
Pliant Therapeutics Inc. (PLRX)
Pluristem Therapeutics, Inc. (PSTI)
Plus Therapeutics Inc. (PSTV)
PolarityTE, Inc. (PTE)
Poseida Therapeutics Inc. (PSTX)
Precigen Inc (PGEN)
Precision BioSciences Inc. (DTIL)
Prevail Therapeutics Inc. (PRVL)
Protalix BioTherapeutics, Inc. (PLX)
Proteon Therapeutics, Inc. (PRTO)
Qiagen N.V. (QGEN)
RAPT Therapeutics Inc. (RAPT)
REGENXBIO Inc. (RGNX)
Relay Therapeutics Inc. (RLAY)
Repligen Corporation (RGEN)
Replimune Group, Inc. (REPL)
Rexahn Pharmaceuticals Inc. (REXN)
Rubius Therapeutics, Inc. (RUBY)
Sangamo Therapeutics, Inc. (SGMO)
Scholar Rock Holding Corporation (SRRK)
Seattle Genetics, Inc. (SGEN)
Seelos Therapeutics Inc. (SEEL)
Seneca Biopharma Inc. (SNCA)
Solid Biosciences Inc. (SLDB)
Sonnet BioTherapeutics Holdings Inc. (SONN)
Spark Therapeutics, Inc. (ONCE)
Stoke Therapeutics Inc. (STOK)
Surface Oncology, Inc. (SURF)
Sutro Biopharma, Inc. (STRO)
Titan Pharmaceuticals, Inc. (TTNP)
TRACON Pharmaceuticals, Inc. (TCON)
Translate Bio, Inc. (TBIO)
TrovaGene, Inc. (TROV)
Twist Bioscience Corporation (TWST)
Vaxart, Inc. (VXRT)
Vaxcyte Inc. (PCVX)
VBI Vaccines, Inc. (VBIV)
Vericel Corporation (VCEL)
Vical Incorporated (VICL)
Viela Bio Inc. (VIE)
Vir Biotechnology Inc. (VIR)
Voyager Therapeutics, Inc. (VYGR)
Windtree Therapeutics Inc. (WINT)
X4 Pharmaceuticals Inc. (XFOR)
Xtant Medical Holdings, Inc. (XTNT)
Zentalis Pharmaceuticals Inc. (ZNTL)
Disclaimer

We believe social network activity can help inform investors of the positive and negative opinions people hold of a company. Social media posts are made both before and after market price changes. We can make no claim of causation or future correlation between market prices and social media sentiment. We make no evaluation or predictions of stock value. We do not endorse any posts on social media which are reposted here.

This page is being provided for informational purposes only, and on the condition that it will not form a primary basis for any investment decision. Investors should make their own determination of whether or not to buy or sell a stock based on their specific investment goals, with proper due diligence, and in consultation with their financial advisor. See financial disclosures on our About the Developer page.

We've trained our artificial intelligence systems from past social media posts. While tests show our predictions are usually accurate to our models, a human may come to a different conclusion for some posts.